AUS
NZ
UK
CA
USA
IND
Healthcare
MedAdvisor Released Strong December 2018 Quarter Results
January 31, 2019 07:00 PM AEDT| By Team Kalkine MediaMedAdvisor Limited (ASX: MDR), is Australia?s leading digital medication management company. MDR has released its Appendix 4C Report for the 3- month period which ended on 31 December 2018. They also provided an overview of their progress which took...
Botanix Pharmaceutical Released Its 2019 Business Outlook
January 31, 2019 04:34 PM AEDT| By Team Kalkine MediaBotanix Pharmaceutical (formerly: Bone Medical) is a pharmaceutical and biotechnology public listed company with the code as [ASX: BOT], which was founded in 2002 and is headquartered at Perth, Australia. It focuses on the treatment of joint and bone...
Creso Pharma Shares Tumbled On ASX On Placement Update By The Company
January 31, 2019 03:27 PM AEDT| By Team Kalkine MediaCreso Pharma Limited (ASX: CPH) is in the cannabis sector. The primary objective of the company is to deliver pharmaceutical expertise with a delivery of the highest quality products in the cannabis domain. The group is developing a presence in many...
GMV Has Successfully Executed ~US$22 Million Purchase Order With Hygea
January 30, 2019 09:23 PM AEDT| By Team Kalkine MediaG Medical Innovations Holdings Limited (ASX: GMV), a company which belongs to the health care industries announced that it has successfully executed purchase orders of US$21.85 million with Hygea Holdings Corp (?Hygea?) and two of its subsidiaries Pa...
Starpharma Announced Its December Quarter Report
January 30, 2019 09:12 PM AEDT| By Team Kalkine MediaStarpharma Holdings Limited (ASX: SPL), has published its Appendix 4C ? Quarterly Cashflow Report for the period ended on 31 December 2018. SPL's cash balance as at 31 December 2018 stood at $44.4 million, with both net operating and investing cash o...
Mayne Pharma Launched Its TOLSURA™ 65mg Capsule In The US
January 30, 2019 07:30 PM AEDT| By Team Kalkine MediaPharmaceutical Firm, Mayne Pharma (ASX: MYX) today (30 January 2019) announced the launch of its TOLSURA? (SUBA?-itraconazole) 65mg capsule in the US. TOLSURA treats fungal infections including histoplasmosis (chronic cavitary pulmonary & non-men...
Creso Pharma Strengthens Its Presence In Switzerland With The Brewing Of OBMJ Beers At Einhorn Bräu
January 30, 2019 06:35 PM AEDT| By Team Kalkine MediaCreso Pharma Limited?(ASX: CPH) is a pharmaceutical company based in New South Wales, Australia. It has one office in Switzerland as well and has entered into the Canadian market by acquiring 100 % shares of Mernova. Mernova, based in Nova Scotia, is...
MMJ Group: Harvest One Launched Satipharm Reformulated CBD Capsules In Europe
January 30, 2019 06:30 PM AEDT| By Team Kalkine MediaGlobal cannabis investment company, MMJ Group Holdings Limited (ASX: MMJ) currently owns 55,557,994 shares in Harvest One for a 30.5 percent shareholding. Harvest One Cannabis Inc. is a global cannabis company which is involved in the development of...
Cann Group Declares Its Quarterly Business Update
January 30, 2019 04:02 PM AEDT| By Team Kalkine MediaCann Group Limited (ASX: CAN) produces and supplies medical cannabis. The Company cultivates, extracts, and breeds medical cannabis for a range of diseases and medical conditions. Cann Group markets its products in Australia. The company has via the...
2 Biotech Stocks - VHT And IPD
January 29, 2019 08:20 PM AEDT| By Team Kalkine MediaThe below mentioned biotech stocks have witnessed a substantial change in their stock price today (29 January 2019). Both the stocks have published price sensitive news today. Let's take a closer look at these stocks: Volpara Health Technologies Lim...
Immuron: Travelan Enters Canada Market With Strong Sales Growth in 1H FY19
January 29, 2019 07:35 PM AEDT| By Team Kalkine MediaBiopharmaceutical company Immuron Limited (ASX: IMC) today released sales results for its commercially available digestive health supplement Travelan? for the first half of the Fiscal Year 2019. Immuron?s Travelan? global sales for the six months en...
CPH Reports 11% Dip Since The Institutional Placement Announcement
January 29, 2019 07:30 PM AEDT| By Team Kalkine MediaCreso Pharma Limited?(ASX: CPH), domiciled in Australia, is a pharmaceutical company with its other offices in Switzerland. It has, further, entered into the Canadian market through the acquisition of a Medical Cannabis company domiciled in Nova Scot...
Opthea Secures Japanese Patent Grant Covering OPT-302
January 29, 2019 07:16 PM AEDT| By Team Kalkine MediaOpthea Limited (ASX:OPT) announces the grant of Japanese Patent Number 6408492 covering its OPT-302 soluble VEGFR-3 (sVEGFR-3) ?trap? molecule.? The patent granted is in the name of Opthea?s wholly-owned subsidiary, Vegenics Pty Limited. Opthea is a...
ImpediMed’s PREVENT Trial Gets An Entry Into Annual Meeting of The American Society Of Breast Surgeons
January 29, 2019 06:41 PM AEDT| By Team Kalkine MediaImpediMed shares bounced over 28% on the announcement of PREVENT trial being accepted for presentation at the 2019 Annual Meeting of the American Society of Breast Surgeons. In today?s announcement to ASX, Medical devices manufacturer, ImpediMed Lim...
Genetic Signatures’ Shares Surged On ASX Owing To Its Second-Quarter FY19 Activity Updates
January 29, 2019 05:15 PM AEDT| By Team Kalkine MediaGenetic Signatures Limited (ASX: GSS) is in Pharmaceuticals, Biotechnology, and Life Sciences industry. The company mainly operates as a molecular diagnostic company. On 29 January 2019, the company has reported its activities for the quarter ended...
SomnoMed Limited Reported Core Revenue Growth of 13% in Q2 FY19
January 29, 2019 03:09 PM AEDT| By Team Kalkine MediaHealthcare company, SomnoMed ?Limited (ASX: SOM) today (i.e., 29 January 2019) announced that its core revenues have increased by 13 percent in the Q2 FY 2019 as compared to the prior year, reaching $15.675 million for the three months period. In th...
Race Oncology Releases Its December Quarter Result Update
January 29, 2019 08:30 AM AEDT| By Team Kalkine MediaOn 25 January 2019, Race Oncology Ltd (ASX: RAC), a pharmaceutical company, has announced its Consolidated Quarterly statement of cash flows. As at 31 December 2018, the Company?s cash balance was AUD 2,079,000, representing a decrease from the cash...
OCA Announces Decent 1HY2019 Results
January 28, 2019 06:07 PM AEDT| By Team Kalkine MediaOceania Healthcare Limited (ASX: OCA) announces its half-yearly results to the market (6 months to 30 November 2018). The underlying NPAT was 5.3% above 1HY2018 and there is 8.7% growth in continuing operations as compared to 1HY2018. OCA is a care f...
Althea Group Announces Achievement Of 300 Patients: What Market Players Need To Know
January 25, 2019 09:30 PM AEDT| By Team Kalkine MediaAlthea Group Holdings (ASX: AGH) had come forward and made an announcement about the patients which were prescribed its medicinal cannabis with the help of the press release. Althea Group Holdings happens to be the licensed producer as well as import...
The Share Price Of Factor Therapeutics Remains Unaffected By The Retirement Of The Chief Executive Officer
January 25, 2019 09:17 PM AEDT| By Team Kalkine MediaBiotechnology Company, Factor Therapeutics Limited (ASX: FTT) today made an announcement regarding a change in the Company's management. In the announcement, the company has informed that Dr. Rosalind Wilson has completed her tenure as Chief Executiv...
Advertise your brand on Kalkine Media